These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

527 related items for PubMed ID: 14668551

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. CK7, CK20, CDX2 and MUC2 Immunohistochemical staining used to distinguish metastatic colorectal carcinoma involving ovary from primary ovarian mucinous adenocarcinoma.
    Shin JH, Bae JH, Lee A, Jung CK, Yim HW, Park JS, Lee KY.
    Jpn J Clin Oncol; 2010 Mar; 40(3):208-13. PubMed ID: 19926591
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. CDX2 immunostaining as a gastrointestinal marker: expression in lung carcinomas is a potential pitfall.
    Mazziotta RM, Borczuk AC, Powell CA, Mansukhani M.
    Appl Immunohistochem Mol Morphol; 2005 Mar; 13(1):55-60. PubMed ID: 15722794
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2.
    McCluggage WG, Shah R, Connolly LE, McBride HA.
    Int J Gynecol Pathol; 2008 Jan; 27(1):92-100. PubMed ID: 18156982
    [Abstract] [Full Text] [Related]

  • 9. SATB2 Expression Distinguishes Ovarian Metastases of Colorectal and Appendiceal Origin From Primary Ovarian Tumors of Mucinous or Endometrioid Type.
    Moh M, Krings G, Ates D, Aysal A, Kim GE, Rabban JT.
    Am J Surg Pathol; 2016 Mar; 40(3):419-32. PubMed ID: 26551622
    [Abstract] [Full Text] [Related]

  • 10. Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry: differential diagnosis between colonic and ovarian carcinomas as primary sites.
    Lagendijk JH, Mullink H, Van Diest PJ, Meijer GA, Meijer CJ.
    Hum Pathol; 1998 May; 29(5):491-7. PubMed ID: 9596273
    [Abstract] [Full Text] [Related]

  • 11. [Detection of CDX-2, CK7 and CK20 in primary and metastatic ovarian carcinoma].
    Yuan ZF, Shi HR, Sun HM, Li WC.
    Zhonghua Bing Li Xue Za Zhi; 2007 Aug; 36(8):555-6. PubMed ID: 17980105
    [No Abstract] [Full Text] [Related]

  • 12. Primary ovarian carcinoid tumors may express CDX-2: a potential pitfall in distinction from metastatic intestinal carcinoid tumors involving the ovary.
    Rabban JT, Lerwill MF, McCluggage WG, Grenert JP, Zaloudek CJ.
    Int J Gynecol Pathol; 2009 Jan; 28(1):41-8. PubMed ID: 19047909
    [Abstract] [Full Text] [Related]

  • 13. Expression of cytokeratin 20 in mucinous bronchioloalveolar carcinoma.
    Shah RN, Badve S, Papreddy K, Schindler S, Laskin WB, Yeldandi AV.
    Hum Pathol; 2002 Sep; 33(9):915-20. PubMed ID: 12378517
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The usefulness of CDX-2 for differentiating primary and metastatic ovarian carcinoma: an immunohistochemical study using a tissue microarray.
    Kim MJ.
    J Korean Med Sci; 2005 Aug; 20(4):643-8. PubMed ID: 16100458
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.